July 2018 Br J Cardiol 2018;25:110 doi:10.5837/bjc.2018.020
George Abraham, Aamir Shamsi, Yousef Daryani
Introduction The European cardiovascular magnetic resonance (EuroCMR) registry1,2 was a multi-national, multi-centre report on the clinical use of cardiac magnetic resonance imaging (CMR) based on data up to 2012 including 27,000 patients. We have collected similar data on 791 consecutive patients based on the use of CMR in our local centre in Epsom, Surrey, UK, from the start of the service until the current time, encompassing a three-year period. This includes information on patient demographics, clinical safety, indications and impact on patient management. The aim of this study was to evaluate if the results of the multi-national European
November 2010 Br J Cardiol 2010; 17:290-92
Alistair C Lindsay, Scott W Murray, Robin P Choudhury
Background: carotid/vascular MRI Figure 1. 3T magnetic resonance imaging (MRI) of atherosclerotic plaque in a right common carotid artery. The vessel wall is lined with complicated, lipid-rich plaque, which has a necrotic core (solid arrow). A thin fibrous cap can be seen in the bottom-left of the image (dashed arrow) Magnetic resonance arteriography (MRA) has for many years been used as a non-invasive means of producing an arterial lumenogram, an image of flow down the arterial lumen, from which the presence of significant stenosis could often be detected, if needed, by comparison to the comparatively normal flow in the contralateral vessel.